Vascular approaches and its potential implications in transcatheter aortic valve implantation

Abstract

Transcatheter aortic valve implantation (TAVI) has become in the last years a primary therapeutic tool in order to treat percutaneously severe aortic stenosis in frail patients with multiple comorbidity and a high surgical risk. In almost all cases, the complexity of patients who are candidates for TAVI is also reflected in challenging access sites. This vascular issue addresses the invasive play of constantly evolving devices and resulting complications have a considerable impact on patient morbidity and mortality. For this reason, the study and the choice of the different access site require the attention and experience of the operators to reach the most reliable and feasible vascular approach for a real procedural success.

Keywords

Transcatheter aortic valve implantation / vascular access site / access complications

References

[1] Baumgartner H,Bax JJ,Hamm C,Iung B,Lansac E,Rosenhek R,Tornos Mas P,Walther T,Windecker S.2017 ESC/EACTS Guidelines for the management of valvular heart disease.Eur Heart J.2017;38:2739-91

[2] Reardon MJ,Popma JJ,Søndergaard L,Adams DH,Maini B,Chetcuti S,Heiser J,Merhi W,Olsen PS,Williams M,Yakubov SJ,Makkar R,Conte J,Nguyen H,Mugglin AS,Kappetein AP.Surgical or transcatheter aortic-valve replacement in intermediate-risk patients.N Engl J Med2017;376:1321-31

[3] Zajarias A.Outcomes and safety of percutaneous aortic valve replacement.J Am Coll Cardiol2009;53:1829-36

[4] Holmes DR,Mack MJ.Transcatheter valve therapy: a professional society overview from the American College of Cardiology Foundation and the Society of Thoracic Surgeons.Ann Thorac Surg2011;92:380-9

[5] Willson AB,Labounty TM,Moss R,Thompson C,Gurvitch R,Hague CJ,Binder R,Poulter R,Wood DA.3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis.J Am Coll Cardiol2012;59:1287-94

[6] Gilard M1,Iung B,Chevreul K,Leprince P,Lievre M,Teiger E,Himbert D,Carrié D,Cribier A,Sudre A,Collet F,Meneveau N,Caussin C,Boschat J,Collart F,Delpine S,Favereau X,Doisy V,Gommeaux A,Bourlon F,Van Belle E.Registry of transcatheter aortic-valve implantation in high-risk patients.N Engl J Med2012;366:1705-15

[7] Webb JG,Boone RH,Ye J,Lee M,Thompson C,Carere R,Nietlispach F.Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes.Circulation2009;119:3009-16

[8] Toggweiler S.Challenges in transcatheter aortic valve implantation.Swiss Med Wkly2012;142:w13735

[9] Thomas M,Walther T,Lefèvre T,Eggebrecht H,Colombo A,Schwarz RR.One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.Circulation2011;124:425-33

[10] Tirado-Conte G,Nombela-Franco L,Biagioni C,Nu-ez-Gil I,Gonzalo N,Vivas D,Viana-Tejedor A,Vilacosta I,Fernandez-Ortiz A.Incidence, causes, and impact of in-hospital infections after transcatheter aortic valve implantation.Am J Cardiol2016;118:403-9

[11] Al-Rashid F,Selge F,Patsalis PC,Mummel P,Jánosi RA.Risk assessment of patients undergoing transfemoral aortic valve implantation upon admission for post-interventional intensive care and surveillance: implications on short- and midterm outcomes.PLoS One2016;11:e0167072 PMCID:PMC5120839

[12] Leon MB,Mack MJ,Svensson LG,Thourani VH,Miller DC,Doshi D,Pichard AD,Dewey T,Szeto WY,Kereiakes D,Greason KL,Hodson RW,Trento A,Fearon WF,Hahn RT,Anderson WN,Webb JG.Transcatheter or surgical aortic-valve replacement in intermediate-risk patients.N Engl J Med2016;374:1609-20

[13] van der Boon RM,Theuns DA,Nauta ST,Jordaens L,de Jaegere PP.Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System.Int J Cardiol2013;168:1269-73

[14] Hayashida K,Chevalier B,Romano M,Mylotte D,Farge A,Bouvier E,Morice MC.True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications.JACC Cardiovasc Interv2012;5:207-14

[15] Sharp AS,Maisano F,Godino C,Denti P,Giacomini A,Manca M,Montorfano M,Colombo A.A new technique for vascular access management in transcatheter aortic valve implantation.Catheter Cardiovasc Interv2010;75:784-93

[16] Dimitriadis Z,Ensminger SM,Bitter T,Vlachojannis M,Faber L,Gummert J.Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the ProGlide closure device.PLoS One2017;12:e0183658 PMCID:PMC5570351

[17] Hayashida K,Chevalier B,Romano M,Mylotte D,Farge A,Bouvier E,Morice MC.True percutaneous approach for transfemoral aortic valve implantation using the Prostar XL device: impact of learning curve on vascular complications.JACC Cardiovasc Interv2012;5:207-14

[18] Jean-Baptiste E,Haudebourg P,Declemy S.Percutaneous closure devices for endovascular repair of infrarenal abdominal aortic aneurysms: a prospective, non-randomized comparative study.Eur J Vasc Endovasc Surg2008;35:422-8

[19] Sharp AS,Maisano F,Godino C,Denti P,Giacomini A,Manca M,Montorfano M,Colombo A.A new technique for vascular access management in transcatheter aortic valve implantation.Catheter Cardiovasc Interv2010;75:784-93

[20] M1 Nakamura,Jilaihawi H,Dohad S,Cheng W.Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure.Catheter Cardiovasc Interv2014;84:293-300

[21] Lichtenstein SV,Ye J,Carere RG,Webb JG.Transapical transcatheter aortic valve implantation in humans: initial clinical experience.Circulation2006;114:591-6

[22] Walther T,van Linden A.Transcatheter aortic valve implantation transapical: step by step.Semin Thorac Cardiovasc Surg2011;23:55-61

[23] Walther T,Dewey T.Transapical aortic valve implantation - procedural steps..In: Serruys PW Piazza N, Cribier A, Webb JG, Laborde JC, de Jaegere P, editors. Transcatheter aortic valve implantation. Tips and tricks to avoid failure.2010;New YorkInforma Healthcare USA, Inc.207-17

[24] Bruschi G,Fratto P,Colombo P,Klugmann S.Direct aortic access through right minithoracotomy for implantation of self-expanding aortic bioprosthetic valves.J Thorac Cardiovasc Surg2010;140:715-7

[25] Bapat VN.Transaortic access is the key to success.EuroIntervention2013;9 Suppl:S25-32

[26] Lardizabal JA,Desai HV,Rodriguez AP,Alfonso CE,Carillo RG,Heldman AW,Williams DB.The transaortic approach for transcatheter aortic valve replacement: initial clinical experience in the United States.J Am Coll Cardiol2013;61:2341-5

[27] Caceres M,Roselli EE.The axillary/subclavian artery access route for transcatheter aortic valve replacement: a systematic review of the literature.Ann Thorac Surg2012;93:1013-8

[28] van Mieghem NM,Oei F,Ligthart J,de Jaegere PP.Completely percutaneous transcatheter aortic valve implantation through transaxillary route: an evolving concept.EuroIntervention2012;7:1340-2

[29] Schäfer U,Frerker C,Sanchez-Quintana D,Bijuklic K,Thielsen T,Kuck KH.Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: “the Hamburg Sankt Georg approach”.JACC Cardiovasc Interv2012;5:477-86

[30] Azmoun A,Ramadan R,Caussin C,Raoux F,Nottin R.Transcatheter aortic valve implantation through carotid artery access under local anaesthesia.Eur J Cardiothorac Surg2014;46:693-8

[31] Guyton RA,Thourani VH,Babaliaros V.Carotid artery access for transcatheter aortic valve replacement.Catheter Cardiovasc Interv2013;82:E583-6

[32] Modine T,Delhaye C,Lemesle G,Koussa M.Transcutaneous aortic valve implantation using the left carotid access: feasibility and early clinical outcomes.Ann Thorac Surg2012;93:1489-94

[33] Halabi M,Faranesh AZ,Schenke WH.Aortic access from the vena cava for large caliber transcatheter cardiovascular interventions: pre-clinical validation.J Am Coll Cardiol2013;61:1745-6 PMCID:PMC3679529

[34] Greenbaum AB,Paone G,Wyman JF,Lederman RJ.Caval-aortic access to allow transcatheter aortic valve replacement in otherwise ineligible patients: initial human experience.J Am Coll Cardiol2014;63:2795-804 PMCID:PMC4105161

[35] Pascual I,Avanzas P,Díaz R,Lorca R,Silva J.Vascular approaches for transcatheter aortic valve implantation.J Thorac Dis2017;9:S478-87 PMCID:PMC5462718

[36] Lederman RJ,Greenbaum AB.How to perform transcaval access and closure for transcatheter aortic valve implantation.Catheter Cardiovasc Interv2015;86:1242-54 PMCID:PMC4740457

[37] Ruparelia N,Buzzatti N,Figini F,Regazzoli D,Sticchi A,Tanaka A,Monaco F,Ancona M,Spagnolo P,Montorfano M,Colombo A.Long-term outcomes after transcatheter aortic valve implantation from a single high-volume center (The Milan Experience).Am J Cardiol2016;117:813-9

[38] Ciuca C,Latib A,Savini C,Napodano M,Gerosa G,Marzocchi A,Colombo A.Trans-subclavian versus transapical access for transcatheter aortic valve implantation: a multicenter study.Catheter Cardiovasc Interv2016;87:332-8

[39] Garcia DC,Cardoso RN,Chavez P,Herzog E,de Marchena E.Device stratified comparison among transfemoral, transapical and transubclavian access for transcatheter aortic valve replacement (TAVR): a meta-analysis.Int J Cardiol2014;172:e318-21

[40] Chandrasekhar J,Ruel M,Labinaz M.Transfemoral vs non-transfemoral access for transcatheter aortic valve implantation: a systematic review and meta-analysis.Can J Cardiol2015;31:1427-38

[41] Shults C,Thourani VH.The versatility of transapical access: will it lead to a completely new approach to valvular therapy?.Ann Cardiothorac Surg2012;1:220-3 PMCID:PMC3741732

[42] Stortecky S,Wenaweser P.Transcatheter aortic valve implantation: the procedure.Heart2012;98:iv44-51

[43] Généreux P,Svensson LG,Satler LF,Davidson CJ,Makkar RR,Babaliaros V,Velazquez OC,Hueter I,Leon MB.Vascular complications after transcatheter aortic valve replacement: insights from the PARTNER (Placement of AoRTic TraNscathetER Valve) trial.J Am Coll Cardiol2012;60:1043-52

[44] Hayashida K,Chevalier B,Romano M,Mylotte D,Farge A,Bouvier E,Morice MC.Transfemoral aortic valve implantation new criteria to predict vascular complications.JACC Cardiovasc Interv2011;4:851-8

[45] Reidy C,Ramakrishna H,Patel PA.Challenges after the first decade of transcatheter aortic valve replacement: focus on vascular complications, stroke, and paravalvular leak.J Cardiothorac Vasc Anesth2013;27:184-9

[46] Toggweiler S,Leipsic J,Willson AB,Cheung A,Webb JG.Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure.J Am Coll Cardiol2012;59:113-8

[47] Di Mario C,Moat N,Ussia GP,Wenaweser P,Nickenig G,Snow T,Zamorano P,Corti R,Prendergast B,Windecker S,Gilard M,Danenberg H,Romeo F,Derumeaux G,Tavazzi L.The 2011-12 pilot European Sentinel Registry of Transcatheter Aortic Valve Implantation: in-hospital results in 4,571 patients.EuroIntervention2013;8:1362-71

[48] Van Mieghem NM,Chieffo A,Messika-Zeitoun D,Vahdat O,Marcheix B,Serruys PW,Colombo A,Vahanian A.Incidence, predictors, and implications of access site complications with transfemoral transcatheter aortic valve implantation.Am J Cardiol2012;110:1361-7

[49] Mussardo M,Chieffo A,Ielasi A,Takagi K,Montorfano M,Carlino M,Covello RD,Grimaldi A,Colombo A.Periprocedural and short-term outcomes of transfemoral transcatheter aortic valve implantation with the Sapien XT as compared with the Edwards Sapien valve.JACC Cardiovasc Interv2011;4:743-50

[50] De Backer O,Sandholt B,Biasco L,Lönn L,Søndergaard L.Safety and efficacy of using the Viabahn endoprosthesis for percutaneous treatment of vascular access complications after transfemoral aortic valve implantation.Am J Cardiol2015;115:1123-9

[51] Starnes BW.Endovascular management of vascular trauma.Perspect Vasc Surg Endovasc Ther2006;18:114-29